Vineti Introduces PTM Essentials™ to Accelerate Cell and Gene Therapy Clinical Trials with a New Digital Supply Chain Solution
May 10, 2021 07:00 ET | Vineti
New PTM Essentials™ solution draws on Vineti’s industry-leading Personalized Therapy Management® (PTM) software platform to deliver breakthrough speed and simplicity for advanced therapy clinical...
Biopharmaceutical and technology leaders form collaboration to promote standards and a modern patient ID for advanced therapies
March 24, 2021 07:00 ET | Vineti
Genentech, Takeda, Adaptimmune and other industry leaders join Vineti to form the core of this strategic collaboration. The group is focused on working industry-wide to promote new and updated...
Introducing new Vineti PTM® flexibility features: next-gen label printing and rescheduling innovations deliver critical workflow options that advanced therapies require
January 11, 2021 09:30 ET | Vineti
New PTM® Label Printing brings unprecedented flexibility and simplicity to a complex process that is critical to product integrity and patient safetyUpdated PTM® Order Status Tracking provides a...
Vineti Registered PTM Mark 2020
Vineti Extends Series C Funding Round to $68M with an Expanded Investor Coalition
October 13, 2020 09:00 ET | Vineti
This $33 million extension to Vineti’s Series C in February 2020 will be used to further grow the company’s leading enterprise platform for advanced therapies and support its mission of...
OncoBay Clinical and Vineti form strategic alliance to deliver integrated clinical trial solutions and supply chain automation for cell and gene therapies
August 25, 2020 09:00 ET | Vineti
TAMPA, Fla. and SAN FRANCISCO, Aug. 25, 2020 (GLOBE NEWSWIRE) -- OncoBay Clinical, Inc., a full-service boutique contract research organization (CRO) specializing in complex oncology programs...
Vineti Announces New Chief Commercial Officer
August 17, 2020 09:00 ET | Vineti
SAN FRANCISCO, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Vineti, Inc., the provider of the leading digital platform of record for personalized therapeutics, today announced the hiring of Joe DePinto as the...
Avobis Bio and Vineti announce strategic collaboration to support new implantable cell therapies addressing debilitating conditions
August 11, 2020 09:00 ET | Vineti
NEWARK, Del. and SAN FRANCISCO, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Today, Avobis Bio, LLC (Avobis Bio), a clinical-stage regenerative therapy company specializing in the development of implantable...
Vineti launches new Alliance Network -- and announces a collaboration with Mavens -- to deliver integrated solutions for cell and gene therapies
June 16, 2020 09:00 ET | Vineti
SAN FRANCISCO and CHICAGO, June 16, 2020 (GLOBE NEWSWIRE) -- Vineti, Inc., the leading provider of cloud-based Personalized Therapy Management (PTM) software for advanced therapies, announced a new...
Vineti Announces New Chief Technology Officer
March 09, 2020 08:00 ET | Vineti
SAN FRANCISCO, March 09, 2020 (GLOBE NEWSWIRE) -- Vineti, Inc., the provider of the leading digital platform of record for personalized therapeutics, today announced the hiring of Phil Calvin as the...
Vineti Completes $35 Million in Series C Financing to Industrialize Personalized and High-Value Therapeutics
February 05, 2020 07:30 ET | Vineti
A coalition of strategic industry leaders – including Cardinal Health, Novartis Pharma AG, and Kite, a Gilead Company (Gilead Sciences, Inc.) – joins the company’s existing investor syndicate to...